Melinta Rips Investor Challenge To Its Confirmed Ch. 11 Plan
Antibiotic developer Melinta Therapeutics has told the Delaware bankruptcy court that it should reject attempts by former stockholders to revisit aspects of the company's already approved Chapter 11 plan, saying they...To view the full article, register now.
Already a subscriber? Click here to view full article